Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Molly Moore

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
International Journal of Clinical Pharmacy|December 2, 2021
Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factorsAdeniyi T Togun, Pinar Karaca Mandic, Rebecca Wurtz, et al.
Health Affairs (Project Hope)|November 5, 2019
Biosimilar Filgrastim Uptake And Costs Among Commercially Insured, Medicare AdvantagePinar Karaca-Mandic, Jessica Chang, Ronald Go, et al.
Obesity Science & Practice|March 12, 2025
Using Metabolic Testing to Personalize Behavioral Obesity TreatmentLeonard H Epstein, John W Apolzan, Molly Moore, et al.
BMC Medical Research Methodology|August 28, 2024
Feasibility of using real-world data to emulate substance use disorder clinical trials: a cross-sectional studyGuneet S Janda, Molly Moore Jeffery, Reshma Ramachandran, et al.
Journal of Occupational and Environmental Medicine|October 30, 2013
The 3-year disease management effect: understanding the positive return on investmentJohn A Nyman, Molly Moore Jeffery, Jean M Abraham, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|May 21, 2013
Emergency department utilization as a measure of physician performanceBryan Dowd, Medha Karmarker, Tami Swenson, et al.
The American Journal of Managed Care|May 25, 2023
Provider barriers in uptake of biosimilars: case study on filgrastimJessica Chang, Pinar Karaca-Mandic, Ronald S Go, et al.
The Journal of Emergency Medicine|May 11, 2024
A Nationwide Emergency Department Data Analysis to Predict Beers List Medications Use Among Older AdultsSangil Lee, Gabrielle Frediani, Brian C Lund, et al.
The American Journal of Managed Care|August 30, 2021
Site of care potentially limits cost savings from biosimilarsJessica Chang, Pinar Karaca-Mandic, Ronald S Go, et al.
BMJ Open|August 17, 2021
Epidemiology of paediatric pain-related visits to emergency departments in the USA: a cross-sectional studyJana L Anderson, Lucas Oliveira J E Silva, Shealeigh A Funni, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
International Journal of Clinical Pharmacy|December 2, 2021
Association of opioid fills with centers for disease control and prevention opioid guidelines and payer coverage policies: physician, insurance and geographic factorsAdeniyi T Togun, Pinar Karaca Mandic, Rebecca Wurtz, et al.
Health Affairs (Project Hope)|November 5, 2019
Biosimilar Filgrastim Uptake And Costs Among Commercially Insured, Medicare AdvantagePinar Karaca-Mandic, Jessica Chang, Ronald Go, et al.
Obesity Science & Practice|March 12, 2025
Using Metabolic Testing to Personalize Behavioral Obesity TreatmentLeonard H Epstein, John W Apolzan, Molly Moore, et al.
BMC Medical Research Methodology|August 28, 2024
Feasibility of using real-world data to emulate substance use disorder clinical trials: a cross-sectional studyGuneet S Janda, Molly Moore Jeffery, Reshma Ramachandran, et al.
Journal of Occupational and Environmental Medicine|October 30, 2013
The 3-year disease management effect: understanding the positive return on investmentJohn A Nyman, Molly Moore Jeffery, Jean M Abraham, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|May 21, 2013
Emergency department utilization as a measure of physician performanceBryan Dowd, Medha Karmarker, Tami Swenson, et al.
The American Journal of Managed Care|May 25, 2023
Provider barriers in uptake of biosimilars: case study on filgrastimJessica Chang, Pinar Karaca-Mandic, Ronald S Go, et al.
The Journal of Emergency Medicine|May 11, 2024
A Nationwide Emergency Department Data Analysis to Predict Beers List Medications Use Among Older AdultsSangil Lee, Gabrielle Frediani, Brian C Lund, et al.
The American Journal of Managed Care|August 30, 2021
Site of care potentially limits cost savings from biosimilarsJessica Chang, Pinar Karaca-Mandic, Ronald S Go, et al.
BMJ Open|August 17, 2021
Epidemiology of paediatric pain-related visits to emergency departments in the USA: a cross-sectional studyJana L Anderson, Lucas Oliveira J E Silva, Shealeigh A Funni, et al.
Pageof 6